WIC
ABBV icon

WealthBridge Investment Counsel’s AbbVie ABBV Stock Holding History

WealthBridge Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.82M Buy
39,036
+350
+0.9% +$75.3K 2.62% 15
2026
Q1 		$8.41M Buy
38,686
+200
+0.5% +$44.4K 2.57% 17
2025
Q4 		$8.79M Buy
38,486
+150
+0.4% +$34.2K 2.64% 16
2025
Q3 		$8.88M Sell
38,336
-300
-0.8% -$61.1K 2.74% 15
2025
Q2 		$7.17M Buy
38,636
+1,045
+3% +$194K 2.33% 18
2025
Q1 		$7.88M Buy
37,591
+345
+0.9% +$67.1K 2.87% 15
2024
Q4 		$6.62M Buy
37,246
+500
+1% +$91.9K 2.43% 19
2024
Q3 		$7.26M Buy
36,746
+195
+0.5% +$36.4K 2.58% 17
2024
Q2 		$6.27M Buy
36,551
+800
+2% +$133K 2.4% 20
2024
Q1 		$6.51M Sell
35,751
-365
-1% -$62.9K 2.42% 22
2023
Q4 		$5.6M Buy
36,116
+600
+2% +$87.5K 2.24% 24
2023
Q3 		$5.29M Sell
35,516
-974
-3% -$143K 2.31% 23
2023
Q2 		$4.92M Buy
36,490
+1,354
+4% +$199K 2.07% 26
2023
Q1 		$5.6M Buy
35,136
+792
+2% +$121K 2.48% 21
2022
Q4 		$5.55M Buy
34,344
+1,188
+4% +$182K 2.43% 20
2022
Q3 		$4.45M Buy
33,156
+2,895
+10% +$415K 2.34% 22
2022
Q2 		$4.63M Buy
30,261
+1,000
+3% +$153K 2.35% 23
2022
Q1 		$4.74M Buy
29,261
+390
+1% +$56.7K 2.09% 25
2021
Q4 		$3.91M Buy
28,871
+9,075
+46% +$1.07M 1.66% 30
2021
Q3 		$2.13M Buy
19,796
+3,350
+20% +$383K 0.96% 33
2021
Q2 		$1.85M Buy
+16,446
New +$1.85M 0.82% 34

Other funds holding ABBV

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

WealthBridge Investment Counsel's ABBV Position: Q2 2026 in Review

WealthBridge Investment Counsel increased its AbbVie (ABBV) stake by 0.9% in Q2 2026, buying an estimated $75.3K and bringing the position to 39,036 shares worth $9.82M. The position accounts for 2.62% of the portfolio, ranked #15.

WealthBridge Investment Counsel first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. 2,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • WealthBridge Investment Counsel held 39,036 shares of AbbVie worth $9.82M as of Q2 2026.
  • WealthBridge Investment Counsel bought 350 AbbVie shares in Q2 2026, an estimated $75.3K.
  • AbbVie made up 2.62% of WealthBridge Investment Counsel's portfolio in Q2 2026, its #15 holding.
  • WealthBridge Investment Counsel first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
  • 2,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on WealthBridge Investment Counsel's 13F filing for Q2 2026, filed 15 Jul 2026.